Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiparameter prediction of myeloid neoplasia risk
Muxin Gu, Sruthi Cheloor Kovilakam, William G. Dunn, et al.
Nature Genetics (2023) Vol. 55, Iss. 9, pp. 1523-1530
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 45
Causes and consequences of clonal hematopoiesis
Lachelle D. Weeks, Benjamin L. Ebert
Blood (2023) Vol. 142, Iss. 26, pp. 2235-2246
Open Access | Times Cited: 40
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche
Susann Winter, Katharina S. Götze, Judith S. Hecker, et al.
Leukemia (2024) Vol. 38, Iss. 5, pp. 936-946
Open Access | Times Cited: 11
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence
Zhuoer Xie, Rami S. Komrokji, Najla Al-Ali, et al.
Blood (2024) Vol. 144, Iss. 19, pp. 2033-2044
Closed Access | Times Cited: 9
T-Cell Cancer after CAR T-Cell Therapy
Emily Mitchell, George S. Vassiliou
New England Journal of Medicine (2024) Vol. 390, Iss. 22, pp. 2120-2121
Closed Access | Times Cited: 8
Clonal Hematopoiesis of Indeterminate Potential in Crohn’s Disease and Ulcerative Colitis
Myvizhi Esai Selvan, Daniel I. Nathan, Daniela Guisado, et al.
Inflammatory Bowel Diseases (2025)
Open Access | Times Cited: 1
Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis
Jasmine Singh, Nancy Li, Elham Ashrafi, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3771-3784
Open Access | Times Cited: 7
Aging and comprehensive molecular profiling in acute myeloid leukemia
Jianfeng Li, Wenyan Cheng, Xiangjie Lin, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 10
Open Access | Times Cited: 6
Haematological setpoints are a stable and patient-specific deep phenotype
Brody H. Foy, Rachel Petherbridge, Maxwell Roth, et al.
Nature (2024)
Closed Access | Times Cited: 6
Clonal hematopoiesis and hematological malignancy
William G. Dunn, Matthew McLoughlin, George S. Vassiliou
Journal of Clinical Investigation (2024) Vol. 134, Iss. 19
Open Access | Times Cited: 4
Clonal Hematopoiesis in Women With Breast Cancer
Christina Mayerhofer, Rachel A. Freedman, Heather A. Parsons, et al.
Journal of Clinical Oncology (2025)
Closed Access
Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis
Sean Wen, Pablo Kuri‐Morales, Fengyuan Hu, et al.
Nature Genetics (2025)
Open Access
Adult Growth Hormone Deficiency (AGHD) and Outcomes (NordiNet and ANSWER)
John D. Carmichael, Atil Y. Kargi, Laura E. Dichtel, et al.
Journal of the Endocrine Society (2025) Vol. 9, Iss. 4
Open Access
Monitoring CH: time to move beyond VAF?
Lachelle D. Weeks
Blood (2025) Vol. 145, Iss. 9, pp. 907-908
Closed Access
Beyond Complete Blood Count Reference Ranges: Exploring Hematologic Setpoints
Elizabeth L. Courville
The Hematologist (2025) Vol. 22, Iss. 2
Open Access
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study
Catherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
The Lancet Haematology (2023) Vol. 11, Iss. 1, pp. e51-e61
Closed Access | Times Cited: 12
The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia
Margarete A. Fabre, George S. Vassiliou
Blood (2023) Vol. 143, Iss. 7, pp. 573-581
Closed Access | Times Cited: 10
Genomic landscape of CCUS compared to MDS and its implications on risk prediction
Sandra Huber, Constance Baer, Stephan Hütter, et al.
Leukemia (2024) Vol. 38, Iss. 7, pp. 1634-1637
Open Access | Times Cited: 3
Considering clonal hematopoiesis of indeterminate potential in space radiation risk analysis for hematologic cancers and cardiovascular disease
Charles M. Werneth, Zarana S. Patel, Moriah S. Thompson, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 3
A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC
Wenbin Xiao, Valentina Nardi, Eytan M. Stein, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
Duc Tran, J. Scott Beeler, Jie Liu, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 15, pp. 3220-3228
Open Access | Times Cited: 2
Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational study
Qianwei Liu, Karin E. Smedby, Huiwen Xue, et al.
EClinicalMedicine (2024) Vol. 74, pp. 102753-102753
Open Access | Times Cited: 2
Can molecular patterns help to classify overlapping entities in myeloid neoplasms?
Gregor Hoermann, Joseph D. Khoury
Histopathology (2024)
Open Access | Times Cited: 2
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders
Qi Zhang, Rita Yim, Paul Lee, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4118-4118
Open Access | Times Cited: 2
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer
Aaron J. Stonestrom, Kamal Menghrajani, Sean M. Devlin, et al.
Blood Advances (2023) Vol. 8, Iss. 4, pp. 846-856
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top